Author

Tomofumi Kimura

Observed names: T Kimura, Tomofumi KIMURA

Observed institutions: Kurume University, Lund University, Tohoku University, Royal University Hospital, University of Saskatchewan, Kurume University Medical Center, Saskatoon Cancer Centre, Nagoya University

OpenAlex ID: A5105398457

Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia

2011 · Chikashi Yoshida, Takuya Komeno, et al. · International Journal of Hematology · 31

Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib

2014 · Naoto Takahashi, Masatomo Miura, et al. · Biomarker Research · 25

Microsatellite mutations of transforming growth factor-β receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation

2002 · Stuart Scott, Tomofumi Kimura, et al. · Leukemia Research · 24

A Novel Process for Preparation of Unsupported Mesoporous Intermetallic NiZn and PdZn Catalysts

2009 · Satoshi Kameoka, Tomofumi Kimura, et al. · Catalysis Letters · 20

Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia

2004 · Stuart A. Scott, Tomofumi Kimura, et al. · Leukemia Research · 16

Development of Diffuse Large B-Cell Lymphoma in a Patient with Waldenström’s Macroglobulinemia/Lymphoplasmacytic Lymphoma: Clonal Identity between Two B-Cell Neoplasms

2011 · Masayuki Shiseki, Akihiro Masuda, et al. · Hematology Reports · 15

Isolation of GnafC, a Polysaccharide Constituent ofGnaphalium affine, and Synergistic Effects of GnafC and Ascorbate on the Phenotypic Expression of Osteoblastic MC3T3-E1 Cells

2003 · Yukihiro AOSHIMA, Yoshinori HASEGAWA, et al. · Bioscience Biotechnology and Biochemistry · 13

Clonal evolution from trisomy into tetrasomy of chromosome 8 associated with the development of acute myeloid leukemia from myelodysplastic syndrome

2001 · Junichi Kameoka, Tadao Funato, et al. · Cancer Genetics and Cytogenetics · 13

Prediction of the cytotoxic effects of some antineoplastic drugs on cultured T-lymphoma cells by microcalorimetry.

1990 · T Kimura, A Schön, et al. · PubMed · 11

Multicenter Phase II Clinical Trial of Nilotinib for Patients with Imatinib-Resistant or Intolerant CML From the East Japan CML Study Group (EJCML) Trial: Evaluation of Molecular Responses by the BCR-ABL1 Mutational Status and Plasma Trough Concentration of Nilotinib

2012 · Naoto Takahashi, Masatomo Miura, et al. · Blood · 5

Relevance of the Daily Dose of Imatinib Mesylate (IM) Rather Than Its Trough Plasma Concentration for Achieving Deep Molecular Response in Patients with Chronic Myeloid Leukemia.

2009 · Chikashi Yoshida, Takuya Komeno, et al. · Blood · 1

Bilateral clavicular fracture and double clavicular fracture, case reports.

1989 · Kimiaki Sato, Hiroshi Hieda, et al. · Orthopedics & Traumatology · 1

Five-year Activities From Inauguration of Ibaraki Prefectural Joint Committee of Blood Transfusion Therapy

2017 · Michihiro Tanikawa, Kyoko Yamaguchi, et al. · Japanese Journal of Transfusion and Cell Therapy

A Case of Malignant Lymphoma of Bone

1989 · Tomofumi Kimura, Masanori Nakashima, et al. · Orthopedics & Traumatology

Questionnaire research of traumatic cervical syndrome.

1988 · Teruyuki Hirohashi, Masato Matsuyama, et al. · Orthopedics & Traumatology

Works count: 15

Citation count: 175

H-index: 9

I10-index: 9